INTRODUCTION AND OBJECTIVES: Prostate cancer (PCa) incidence is higher in African Americans (AA) compared to European Americans (EA) and higher in Western countries. The recent dramatic increase in the polyunsaturated fatty acid (PUFA) linoleic acid (LA) in the modern Western diet may influence PCa risk; LA is converted to arachidonic acid (ARA), which is further metabolized into pro-inflammatory and tumorigenic mediators. Common genetic variants in desaturase genes (FADS1 and FADS2) alter intrinsic conversion of LA to ARA, with the single nucleotide polymorphism rs174537 G allele most strongly associated with high efficiency conversion. Approximately 80% of AA, compared to e45% of EA, are GG at rs174537. We sought to determine the impact of rs174537 in AA and EA on PUFA metabolism and PCa aggressiveness.
METHODS: A subset of PCaP (N¼319, 138 AA, 181 EA), a biracial population of men with PCa, was genotyped at rs174537. PUFAs were quantitated from plasma samples via FAME using GC/FID. PCa tissue was histologically scored by pathologists. Linear, logistic and Cox proportional hazards models, stratified by ethnicity and adjusted for age and admixture, were used to test associations between rs174537, PUFAs, and PCa aggressiveness.
RESULTS: AA had higher ARA/dihomo-g-linolenic acid (DGLA) ratio (a surrogate for FADS1 activity) compared to EA (p<0.05). GG genotype at rs174537 is associated with higher ARA/DGLA in EA (p<0.001) and, although in the same direction, not significantly in AA (p¼0.30). Higher ARA/DGLA ratio was associated with 
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